157 related articles for article (PubMed ID: 16186333)
1. Vitreous: a barrier to nonviral ocular gene therapy.
Peeters L; Sanders NN; Braeckmans K; Boussery K; Van de Voorde J; De Smedt SC; Demeester J
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3553-61. PubMed ID: 16186333
[TBL] [Abstract][Full Text] [Related]
2. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers.
Pitkänen L; Ruponen M; Nieminen J; Urtti A
Pharm Res; 2003 Apr; 20(4):576-83. PubMed ID: 12739764
[TBL] [Abstract][Full Text] [Related]
3. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236
[TBL] [Abstract][Full Text] [Related]
4. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K
J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806
[TBL] [Abstract][Full Text] [Related]
5. The obstacle course to the inner retina: Hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane.
Devoldere J; Wels M; Peynshaert K; Dewitte H; De Smedt SC; Remaut K
Eur J Pharm Biopharm; 2019 Aug; 141():161-171. PubMed ID: 31150809
[TBL] [Abstract][Full Text] [Related]
6. Can ultrasound solve the transport barrier of the neural retina?
Peeters L; Lentacker I; Vandenbroucke RE; Lucas B; Demeester J; Sanders NN; De Smedt SC
Pharm Res; 2008 Nov; 25(11):2657-65. PubMed ID: 18649123
[TBL] [Abstract][Full Text] [Related]
7. Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer.
Sanders NN; Peeters L; Lentacker I; Demeester J; De Smedt SC
J Control Release; 2007 Oct; 122(3):226-35. PubMed ID: 17574287
[TBL] [Abstract][Full Text] [Related]
8. Effect of particle size of polymeric nanospheres on intravitreal kinetics.
Sakurai E; Ozeki H; Kunou N; Ogura Y
Ophthalmic Res; 2001; 33(1):31-6. PubMed ID: 11114602
[TBL] [Abstract][Full Text] [Related]
9. Challenges in non-viral ocular gene transfer.
Peeters L; Sanders NN; Demeester J; De Smedt SC
Biochem Soc Trans; 2007 Feb; 35(Pt 1):47-9. PubMed ID: 17233598
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles.
Tan LE; Orilla W; Hughes PM; Tsai S; Burke JA; Wilson CG
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1111-8. PubMed ID: 20881289
[TBL] [Abstract][Full Text] [Related]
11. The diffusion dynamics of PEGylated liposomes in the intact vitreous of the ex vivo porcine eye: A fluorescence correlation spectroscopy and biodistribution study.
Eriksen AZ; Brewer J; Andresen TL; Urquhart AJ
Int J Pharm; 2017 Apr; 522(1-2):90-97. PubMed ID: 28267579
[TBL] [Abstract][Full Text] [Related]
12. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells.
Peeters L; Sanders NN; Jones A; Demeester J; De Smedt SC
J Control Release; 2007 Aug; 121(3):208-17. PubMed ID: 17630013
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo.
Xu Q; Boylan NJ; Suk JS; Wang YY; Nance EA; Yang JC; McDonnell PJ; Cone RA; Duh EJ; Hanes J
J Control Release; 2013 Apr; 167(1):76-84. PubMed ID: 23369761
[TBL] [Abstract][Full Text] [Related]
14. Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy.
Martens TF; Vercauteren D; Forier K; Deschout H; Remaut K; Paesen R; Ameloot M; Engbersen JF; Demeester J; De Smedt SC; Braeckmans K
Nanomedicine (Lond); 2013 Dec; 8(12):1955-68. PubMed ID: 23438206
[TBL] [Abstract][Full Text] [Related]
15. Novel Liposome Aggregate Platform (LAP) system for sustained retention of drugs in the posterior ocular segment following intravitreal injection.
Blazaki S; Pachis K; Tzatzarakis M; Tsilimbaris M; Antimisiaris SG
Int J Pharm; 2020 Feb; 576():118987. PubMed ID: 31870961
[TBL] [Abstract][Full Text] [Related]
16. Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations.
Thakur SS; Shenoy SK; Suk JS; Hanes JS; Rupenthal ID
Eur J Pharm Biopharm; 2020 Mar; 148():118-125. PubMed ID: 31981693
[TBL] [Abstract][Full Text] [Related]
17. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
Abu Lila AS; Uehara Y; Ishida T; Kiwada H
J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
[TBL] [Abstract][Full Text] [Related]
18. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model.
Pitkänen L; Pelkonen J; Ruponen M; Rönkkö S; Urtti A
AAPS J; 2004 Oct; 6(3):e25. PubMed ID: 15760110
[TBL] [Abstract][Full Text] [Related]
19. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
20. Vitreous variation in vitreous fluorophotometry.
Ross S; Arffa R; Miller D; Weiss JN; Ransil BJ
Ann Ophthalmol; 1982 Mar; 14(3):245-9. PubMed ID: 7092034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
